AAV2-hAQP1 Concentration 3 clinical trials

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

This study looks at a new gene therapy called AAV2-hAQP1 for people who have very dry mouths (xerostomia) after radiotherapy for cancer. It aims to see if it's safe and helps produce more saliva.